It has been reported that the expression level of OX40 on Tregs is much higher than that on CD8+T cells in many types of tumors (17–19), suggesting the tumor inhibition mechanism of OX40 antibody may be predominantly mediated via Treg suppression. This evidence concerns the gene TNFRSF4 and neoplasm.